ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "OccPod: COVID Conversations – Episode 18, Vaccine Boosters"
Episode Synopsis
Thank you for joining us for episode 18 of COVID Conversations. This series is a special presentation of OccPod, the official podcast of the American College of Occupational and Environmental Medicine. ACOEM is dedicated to sharing the latest COVID-19 news, and host conversations grounded in science with a focus on OEM, or occupational and environmental medicine.
In this episode, Erin, Dr. Nabeel, and Dr. Berenji discuss current guidance – and the future implications – of COVID-19 booster shots. Although current guidance recommends additional doses for immunocompromised and older patients, their use could become widespread. Since December 2020, the Pfizer-BioNTech COVID-19 vaccine has been available under Emergency Use Authorization (EUA). EUAs are used by the Food and Drug Administration (FDA) during public health emergencies to provide access to medical products that may be effective, provided that the FDA determines that the known and potential benefits of a product outweigh the known and potential risks. On August 23, 2021, the FDA issued a full approval for the vaccine, now marketed as Comirnaty, for use in individuals in ages 16 years of age and older. Thank you for listening!
In this episode, Erin, Dr. Nabeel, and Dr. Berenji discuss current guidance – and the future implications – of COVID-19 booster shots. Although current guidance recommends additional doses for immunocompromised and older patients, their use could become widespread. Since December 2020, the Pfizer-BioNTech COVID-19 vaccine has been available under Emergency Use Authorization (EUA). EUAs are used by the Food and Drug Administration (FDA) during public health emergencies to provide access to medical products that may be effective, provided that the FDA determines that the known and potential benefits of a product outweigh the known and potential risks. On August 23, 2021, the FDA issued a full approval for the vaccine, now marketed as Comirnaty, for use in individuals in ages 16 years of age and older. Thank you for listening!
More episodes of the podcast OccPod: the official ACOEM podcast
OccPod – Episode 63, Private Practice in OEM
10/12/2024
OccPod – Episode 61, The OEM Pipeline
21/08/2024
In God we trust